EN IT

PHIO — Phio Pharmaceuticals Corp. | Setup 8-12 Jun 2026

PHIO
Phio Pharmaceuticals Corp.
Updated: 2026-06-13 · [ 8-12 Jun 2026 ]
Stock · US
Inside composite NTZ, transitioning bias
SCORE IQS Lite
34/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Structure 1W 15
Momentum 1D 13
Ichimoku 1W 0
CMF 1D 0
Delta 6
IQS Lite Components · What they measure
STRUCTURE 1W15/30MOMENTUM 1D13/35ICHIMOKU 1W0/19CMF 1D0/6DELTA6/10
IQS Lite Components · What they measure
Structure 1W — MA alignment and solidity of the underlying trend
Momentum 1D — Directional strength and momentum acceleration
Ichimoku 1W — Price position relative to the Kumo cloud
CMF 1D — Capital pressure: inflows or outflows
Delta — IQS score change vs previous week (W-1)
Each axis ranges 0-20 pt · sum = total IQS Lite (0-100)
Executive View
Compressed structure with IQS at 34 (compressed phase) suggests expansion potential, but daily and weekly MACD showing Bullish fading limits momentum in the near term. Await confirmation on break above NTZ_sup 1.12 before activating long.
📅 Earnings: 2026-08-06
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn